Re: Why now?
in response to
by
posted on
Jan 12, 2021 10:38AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
CCD, have you not been keeping up with the ZHCLF- Zenith Capital Corp OTCMarket quotes for the stock. That is what TD is following to adjust the share price.
Not in my account. For the past many months it has been $1.00 US, every day. It's only in the last few days that it has dropped below that.